Company news

July 17, 2012 at 12:33AM

MERGERS AND ACQUISITIONS Wilson Wolf Corp., New Brighton, has entered into an asset purchase agreement with Wheaton under which Wheaton has acquired the Cellline Bioreactor Flask product line and will commercialize other Wilson Wolf technology directed at the production of cell-secreted proteins such as antibody and recombinant protein.

about the writer

about the writer

More from Business

In this June 7, 2018, photo the logo for the Vanguard Group is shown on correspondence in Zelienople, Pa. Vanguard said Monday, July 2, that it will stop charging commissions to trade most of its competitors’ exchange-traded funds. (AP Photo/Keith Srakocic)
card image